Pfizer just announced that its Lyme disease vaccine reduced the number of tick-borne infections by over 70% in a phase 3 trial.

Warning: GSK pulled a Lyme vaccine in 2002 despite studies showing it posed no serious safety risks.

Any new Lyme vaccine is going to be a huge target for antivaxxers.